7K81
KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-05-05 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.954 |
Spacegroup name | P 1 |
Unit cell lengths | 47.807, 61.385, 66.989 |
Unit cell angles | 94.32, 99.82, 105.97 |
Refinement procedure
Resolution | 34.020 - 2.000 |
R-factor | 0.1928 |
Rwork | 0.190 |
R-free | 0.24260 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3vh8 |
RMSD bond length | 0.003 |
RMSD bond angle | 0.730 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX ((1.18.2_3874: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 34.020 | 2.110 |
High resolution limit [Å] | 2.000 | 2.000 |
Rmerge | 0.090 | 0.390 |
Number of reflections | 46315 | 25532 |
<I/σ(I)> | 8.4 | 2.9 |
Completeness [%] | 96.0 | 95 |
Redundancy | 3.5 | 3.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.6 | 298 | 14% PEG 3350, 2% tacsimate, pH 5.0, and 0.1 M trisodium citrate, pH 5.6 |